therapy for pregnant women. Neurol Med Chir (Tokyo). 2013;53(8):526-30. \[[PubMed: 23979047](https://pubmed.ncbi.nlm.nih.gov/23979047)\] 20. Lin KJ, Singer DE, Glynn RJ, Blackley S, Zhou L, Liu J, Dube G, Oertel LB, Schneeweiss S. Prediction Score for Anticoagulation Control Quality Among Older Adults. J Am Heart Assoc. 2017 Oct 05;6(10) \[[PMC free article: PMC5721874](/pmc/articles/PMC5721874/)\] \[[PubMed: 28982676](https://pubmed.ncbi.nlm.nih.gov/28982676)\] 21. Winter WE, Flax SD, Harris NS. Coagulation Testing in the Core Laboratory. Lab Med. 2017 Nov 08;48(4):295-313. \[[PubMed: 29126301](https://pubmed.ncbi.nlm.nih.gov/29126301)\] 22. Nutescu EA, Wittkowsky AK, Burnett A, Merli GJ, Ansell JE, Garcia DA. Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum. Ann Pharmacother. 2013 May;47(5):714-24. \[[PMC free article: PMC3815430](/pmc/articles/PMC3815430/)\] \[[PubMed: 23585642](https://pubmed.ncbi.nlm.nih.gov/23585642)\] 23. Wilson SE, Douketis JD, Crowther MA. Treatment of warfarin-associated coagulopathy: a physician survey. Chest. 2001 Dec;120(6):1972-6. \[[PubMed: 11742930](https://pubmed.ncbi.nlm.nih.gov/11742930)\] 24. Su Z, Zhang H, He W, Ma J, Zeng J, Jiang X. Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation. Medicine (Baltimore). 2020 May;99(18):e19542. \[[PMC free article: PMC7440306](/pmc/articles/PMC7440306/)\] \[[PubMed: 32358343](https://pubmed.ncbi.nlm.nih.gov/32358343)\] 25. Rowe AS, Dietrich S, Hamilton LA. Analysis of anticoagulation reversal survey (ARES). Hosp Pract (1995). 2020 Aug;48(3):123-127. \[[PubMed: 32295428](https://pubmed.ncbi.nlm.nih.gov/32295428)\] 26. Maarse M, Swaans MJ, Boersma LVA. Postprocedural Management: Anticoagulation and Beyond. Card Electrophysiol Clin. 2020 Mar;12(1):77-88. \[[PubMed: 32067650](https://pubmed.ncbi.nlm.nih.gov/32067650)\] 27. Bell BR, Spyropoulos AC, Douketis JD. Perioperative Management of the Direct Oral Anticoagulants: A Case-Based Review. Hematol Oncol Clin North Am. 2016 Oct;30(5):1073-84. \[[PubMed: 27637308](https://pubmed.ncbi.nlm.nih.gov/27637308)\] 28. Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med. 2008 Jan 14;168(1):63-9. \[[PubMed: 18195197](https://pubmed.ncbi.nlm.nih.gov/18195197)\] 29. Bhalla V, Lamping OF, Abdel-Latif A, Bhalla M, Ziada K, Smyth SS. Contemporary Meta-Analysis of Extended Direct-Acting Oral Anticoagulant Thromboprophylaxis to Prevent Venous Thromboembolism. Am J Med. 2020 Sep;133(9):1074-1081.e8. \[[PubMed: 32151593](https://pubmed.ncbi.nlm.nih.gov/32151593)\] 30. Ding WY, Harrison S, Gupta D, Lip GYH, Lane DA. Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies. Front Med (Lausanne). 2020;7:54. \[[PMC free article: PMC7047213](/pmc/articles/PMC7047213/)\] \[[PubMed: 32154260](https://pubmed.ncbi.nlm.nih.gov/32154260)\] 31. Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Eichinger S, Kyrle PA, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Prins MH, Sabri E, Hutton B, Pinede L, Cushman M, Palareti G, Wells GA, Prandoni P, BÃ¼ller HR, Rodger MA., MARVELOUS Collaborators. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism